Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02687139Completed
Open-label, single-arm trial, sponsored by Johns Hopkins University. Primary endpoints: Number of Participants With 18F-DCFPyL PET/CT Detected Sites of Metastatic Renal Cell Carcinoma (RCC) at 12 months and Number of Participants With a Correlation Between Radiotracer Uptake on 18F-DCFPyL PET/CT and Conventional Imaging at 12 months. Started Oct 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02687139.